drugset / Trial / NCT02359201
Assessment of V0018 1.5 mg Effect on Craving
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the reduction of craving after administration of V0018 1.5 mg compared to placebo in healthy moderately dependent smokers.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VANILLYL ALCOHOL | Small molecule | 1.5 mg | Other |
Indications
No indication recorded.